Clinical Trial Update: Outcome of ADPKD With Octreotide LAR

View source ↗

Summary

An update on a clinical trial evaluating octreotide long-acting release for autosomal dominant polycystic kidney disease (ADPKD). The trial is not recruiting an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• Octreotide LAR (octreotide long-acting release)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Autosomal Dominant Polycystic Kidney | Status: ACTIVE_NOT_RECRUITING